Lifebit

London, United Kingdom All United Kingdom companies → — Founded 2017

AI Research Lab Biotech / Drug Discovery Healthcare Analytics / BI

Laboratory Medicine Oncology Pathology

Drug Discovery & Research Population Health Analytics

Series B

Website Claim this company

Products

Lifebit Federated Research & Discovery

Lifebit

Drug Discovery & Research

Lifebit Federated Research & Discovery is a federated data platform with AI-powered harmonization for secure, compliant real-world data analytics, enabling research without moving sensitive data.

Contact for pricing

See all 1 product →

About Lifebit

Lifebit is a healthcare AI company that specializes in advanced genomics and health data solutions, offering innovative software designed to enhance the access and analysis of biomedical data across multiple sectors. The company’s core mission is to democratize access to global biomedical data, allowing researchers, organizations, and public bodies to access and analyze vital information in the pursuit of life-changing precision medicine and drug discovery. Lifebit’s platform brings analysis directly to where the data resides, accelerating drug discovery, personalized medicine, and disease research.

For physicians, Lifebit provides solutions that aim to streamline end-to-end clinical and Next-Generation Sequencing (NGS) analysis with AI and advanced analytics. Their offerings include a Trusted Clinical Environment (TCE) that enables secure, compliant environments for transforming data into validated clinical outcomes. The TCE utilizes AI-driven analytics for deep clinical and molecular data interpretation, scrutinizing patient-specific genomic data to detect significant genetic variants that could inform therapeutic strategies. Physicians can also benefit from variant filtering and therapy recommendations by accessing renowned databases, as well as pharmacogenomic reporting to guide treatment and dosage. Lifebit’s Clinical Genomics Portal v2 further enhances these capabilities by integrating AI and advanced software with genomic and health data to improve data management, diagnostics, and personalized treatments, including seamless integration with major Electronic Health Record (EHR) systems like EPIC and Cerner.

Focus Areas

genomics bioinformatics precision medicine health data solutions AI-powered data analytics federated learning drug discovery clinical trials population genomics real-world data (RWD)

Business Intelligence

Technology

Lifebit Federated Platform (Lifebit CloudOS), federated lakehouse architecture, cloud-native, AI-Automated Airlock, Trusted Research Environment (TRE), Trusted Data Lakehouse (TDL), Trusted Data Marketplace (TDM), Nextflow, Kubernetes, Docker, Spark, JupyterLab, RStudio

What Physicians Need to Know

Genomics & Bioinformatics

Lifebit specializes in secure and compliant access to genomic and biomedical data, offering a unified computational environment for managing, processing, analyzing, and sharing complex biological datasets. They automate data ingestion, quality control, and provide workflow orchestration for reproducible and scalable bioinformatics pipelines, supporting diverse formats like FASTQ, BAM/CRAM, and VCF.

Precision Medicine & Health Data Solutions

Lifebit's Federated Platform is purpose-built for precision medicine, harnessing multi-modal and multi-omic data to generate transformative insights. They enable secure and safe access to genomic and biomedical data through Trusted Research Environments (TREs), also known as 'Data Safe Havens,' which are highly secure and controlled computing environments. Their solutions support the transformation of health data management, including standardization to OMOP, FHIR, and GA4GH standards.

AI-Powered Data Analytics & Federated Learning

Lifebit is a global leader in federated, secure, and AI-powered data intelligence platforms. They enable AI-driven analytics by bringing computation to the data, allowing institutions to train powerful AI models on distributed datasets without sharing sensitive patient information. Their AI-Powered Federated Data Hubs allow natural language queries to be converted into federated SQL queries, making complex data exploration accessible.

Drug Discovery & Clinical Trials

Lifebit accelerates drug discovery by enabling secure, real-time AI-powered drug discovery through federated data platforms. Their solutions support target identification and validation by integrating population genomics, clinical data, and biomedical knowledge. For clinical trials, Lifebit provides solutions to unify data, accelerate timelines, and enhance patient engagement, offering secure platforms to connect, manage, and analyze clinical trial data.

Population Genomics & Real-World Data (RWD)

Lifebit's Federated Platform enables secure data harmonization and federated analysis across national biobanks, health systems, and research centers for population genomics, without moving sensitive data. They provide secure access to real-world data (RWD) for oncology research and other therapeutic areas, integrating phenotypic, genomic, pathology, imaging, and treatment outcome data to understand disease biology and personalize treatment plans.

Physician Tip

For physicians, Lifebit's platform offers several key advantages. The **Trusted Clinical Environment** aims to turn data into clinical actions, providing tools for secure exploration of clinical and genomic records to group patients by biomarker, disease, or therapy match, aiding in identifying those who may benefit from precision interventions. The platform includes built-in tools to classify variants using ACMG/AMP standards, prioritize actionable mutations, and surface therapy and trial matches. Automated, configurable reporting generates real-time, dynamic clinical reports, ensuring accurate and up-to-date patient data for authorized personnel. The no-code, user-friendly interface is designed for clinicians, simplifying user interaction. Furthermore, the platform's federated learning approach ensures that sensitive patient data remains secure within its original environment, addressing privacy concerns while still enabling large-scale research and insights.

Lifebit embraces open source, open standards, and an integration-first approach, offering maximum flexibility. Their platform is infrastructure-agnostic and integrates seamlessly with existing systems, including EHRs, national data lakes, databases, and Health Information Exchanges (HIEs). They support data standardization and harmonization using industry best practices like OMOP, FHIR, and GA4GH. The platform also allows for the execution of complex bioinformatics pipelines using frameworks like Nextflow and supports containerized tools and web applications.

At a glance

Founded 2017

HQ London, United Kingdom · United Kingdom

CEO Dr. Maria Chatzou Dunford

Funding Series B

Products 1

Visit site

Products by Lifebit

1 product in the directory

Lifebit Federated Research & Discovery

Lifebit

Drug Discovery & Research

Lifebit Federated Research & Discovery is a federated data platform with AI-powered harmonization for secure, compliant real-world data analytics, enabling research without moving sensitive data.

Contact for pricing

Reviews & Opinions

No web reviews on file yet for Lifebit. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Lifebit.

Loading videos...

Videos load interactively. If none appear, search YouTube for Lifebit →

View all on YouTube

Press & Coverage

EIN News

The World's Most Important Health Data Can't Use Frontier AI. Until Now: Lifebit Launches AI Scientist Studio

Lifebit launched its AI Scientist Studio, a model-agnostic platform that allows researchers to build and deploy custom AI scientist agents within Federated Trusted Research Environments, ensuring data never leaves its source. This innovation enables the use of frontier AI models on governed health data.

2026-09

Lifebit Announcements

Lifebit Awarded Three-Year Contract to Provide the Trusted Research Environment for the NIHR BioResource

Lifebit has been awarded a three-year contract by the University of Cambridge to provide the Trusted Research Environment for the NIHR BioResource, deploying its federated TRE natively in AWS. This will provide a secure space for researchers to access and use data.

2026-09

Lifebit Announcements

Boehringer Ingelheim and Lifebit Extend Collaboration to Accelerate Clinical Data Reuse in Early Discovery

Boehringer Ingelheim and Lifebit have renewed their three-year partnership, deepening the use of a secure, federated Trusted Research Environment to accelerate clinical data reuse in early discovery.

2026-09

Genomics England

Genomics England selects Lifebit for enhanced research environment to enable cutting-edge genomic research

Genomics England is collaborating with Lifebit to develop a next-generation research environment to support advanced genomic research into rare conditions and cancer. This enhanced platform will facilitate more complex analysis and improve usability for researchers.

2026-07

Lifebit

Lifebit Launches Rapid Data Products for Instant Research

Lifebit introduced Rapid Data Products, offering biopharma and research organizations instant access to deeply curated, multimodal real-world datasets through a streamlined procurement and data access experience. This aims to accelerate discovery and eliminate procurement delays.

2025-11

EIN Presswire

Lifebit Launches AI-Automated Airlock to Transform Compliance in Biomedical Results Data Exports

Lifebit unveiled its AI-Automated Airlock, an AI-powered solution designed to automate compliant results data exports across global health research environments. This innovation aims to enhance compliance, transparency, and efficiency in managing sensitive biomedical data exports.

2025-10

Lifebit

Lifebit Launches AI-Powered Biomedical Data Platform

Lifebit officially launched two new AI-powered products, Trusted Data Factory (TDF) and Trusted Target ID (TTID), at BioTechX 2025. These solutions aim to transform biomedical data harmonization and accelerate target discovery.

2025-10

Business Wire

Lifebit and Flatiron Health Bring Cutting-Edge Research Technology to Japan, Advancing Global Cancer Care through Real-World Data

Lifebit and Flatiron Health are expanding their collaboration into Japan to transform cancer care by facilitating groundbreaking research through secure access to real-world data (RWD). Lifebit's federated Trusted Research Environment (TRE) technology will enable safe access to Flatiron Health's high-quality oncology RWD.

2024-10

Frequently Asked Questions

What specific problems does Lifebit solve for physicians and healthcare administrators in precision medicine and genomics?

Lifebit addresses the challenges of securely accessing and analyzing vast, siloed genomic and biomedical data for precision medicine. Their platform enables healthcare professionals to integrate EHR, genomic, and lab data to accelerate diagnoses, personalize treatments, and advance clinical research, all while maintaining data privacy and compliance.

How does Lifebit ensure the security and compliance of sensitive health data, especially real-world data (RWD)?

Lifebit utilizes a federated, security-by-design architecture that allows analysis on distributed datasets without moving the sensitive information, ensuring data remains in its original secure environment. Their platform is compliant with regulations such as HIPAA, GDPR, ISO 27001, SOC 2, FedRAMP, and NIST 800-53, and includes features like AI-Automated Airlock for secure data export governance.

What are Lifebit's key products and how do they leverage AI for data analytics and drug discovery?

Lifebit offers an AI-enhanced Health Data Ecosystem with modules like the Trusted Research Environment (TRE) for secure analysis, Trusted Data Lakehouse for data management, and Trusted Clinical Environment for clinical actions. Their AI-powered tools facilitate target identification, real-time drug side effect surveillance, and accelerate drug discovery by analyzing multi-omic data and optimizing clinical trials.

Can Lifebit's platform be integrated with existing hospital systems and how does it support clinical workflows?

Yes, Lifebit's platform is designed for seamless integration with existing systems like EHRs (Epic, Cerner) and national data lakes. It enhances clinical workflows by providing tools for cohort building, variant interpretation, therapy recommendations, and generating traceable clinical reports directly within the Trusted Clinical Environment.

What is Lifebit's approach to federated learning and how does it benefit healthcare organizations?

Lifebit is a pioneer in federated learning, which allows AI models to be trained on data from multiple institutions without the data ever leaving its source. This approach protects patient privacy, breaks down data silos, and enables large-scale, collaborative research on diverse datasets for precision medicine and drug development.

What kind of partnerships does Lifebit have, and what does this indicate about their market position and stability?

Lifebit has established partnerships with prominent organizations such as the NIH, Genomics England, 23andMe, Flatiron Health, CanPath, and Boehringer Ingelheim. These collaborations demonstrate their credibility and integration into major health data ecosystems, and their substantial Series B funding round led by Tiger Global indicates strong investor confidence and financial stability.

How does Lifebit support population genomics initiatives and real-world data (RWD) research?

Lifebit's Federated Platform is crucial for population genomics, enabling secure data harmonization and federated analysis across national biobanks, health systems, and research centers without moving sensitive data. They provide secure access to diverse RWD from millions of patients, facilitating compliant research and accelerating insights for biomarker discovery and therapeutic target validation.